Microbicides

Insights on the Carrageenan Global Market to 2028 - by Product, Function, Application and Regions - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 18, 2021
Retail, Natural Resources, Other Natural Resources, Food, Beverage, Food and drink, Foods, Food additives, Polysaccharides, Carrageenan, Microbicides, Gels, Thickening agent, Chondrus crispus, Gelatin dessert, Lion

b'The "Carrageenan Market Share, Size, Trends, Industry Analysis Report, By Product; By Function; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global carrageenan market size is expected to reach USD 1.18 billion by 2028 according to a new study.

Key Points: 
  • b'The "Carrageenan Market Share, Size, Trends, Industry Analysis Report, By Product; By Function; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global carrageenan market size is expected to reach USD 1.18 billion by 2028 according to a new study.
  • The growing demand for natural baked foods and the rising trend for healthy snacks is expected to drive the product demand.
  • Moreover, the growing use of carrageenan as a thickening and gelling agent in bakery products is also increasing the segment\'s market growth prospects.\nThe pharmaceutical market segment is project ted to hold revenue share.
  • Carrageenan is used as excipients in drug delivery systems as suspender, wetting agent, solubilizing agent, stabilizer, and adhesive agent.

PHASE 1 TEST RESULTS FOR A NOVEL HIV PREVENTION GEL PRESENTED AT THE HIVR4P MEETING

Retrieved on: 
Thursday, January 28, 2021
Microbicides, Prevention of HIV/AIDS, Sexually transmitted diseases and infections, Medical specialties, HIV/AIDS, Pandemics, Microbiology, Branches of biology, Rectal microbicide, Microbicides for sexually transmitted diseases

The OB-002H-101 Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of the OB-002H gel which is being developed for a HIV prevention indication.

Key Points: 
  • The OB-002H-101 Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of the OB-002H gel which is being developed for a HIV prevention indication.
  • Stage 1 was an open-label single-dose vaginal or rectal application of the OB-002H gel in 12 participants.
  • Dr. Ian McGowan, Chief Medical Officer at Orion Biotechnology stated, We are delighted to have the opportunity to present our Phase 1 data for the OB-002H gel at the HIVR4P meeting.
  • There remains a significant unmet need for HIV prevention products that women and men can use to protect themselves from HIV infection.

Hanmi presents solution package strategy to potentially overcome COVID-19 at the 39th JP Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 12, 2021
Health sciences, Medicine, Health, Hanmi, Polysaccharides, Microbicides, Carrageenan, Vaccines, Nasal spray, DNA vaccine, Pharmaceutical industry

Pyeongtaek Bio Plant possesses a GMP facility where bulk drug substances of mRNA and pDNA vaccines can be produced.

Key Points: 
  • Pyeongtaek Bio Plant possesses a GMP facility where bulk drug substances of mRNA and pDNA vaccines can be produced.
  • Hanmi Pharmaceutical Co., Ltd. is developing a full package to handle the prevention, diagnosis, and treatment of COVID-19.
  • Hanmi recently released 'Hanmi Cold-Mask nasal spray', whose main ingredient is -carrageenan (lambda-carrageenan) extract that can prevent respiratory viral infection.
  • Hanmi Bio Plant has two production buildings (Production Buildings 1 and 2) at the site with an area of 51,498 m2.

Hanmi presents solution package strategy to potentially overcome COVID-19 at the 39th JP Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 12, 2021
Health sciences, Medicine, Health, Hanmi, Polysaccharides, Microbicides, Carrageenan, Vaccines, Nasal spray, DNA vaccine, Pharmaceutical industry

Pyeongtaek Bio Plant possesses a GMP facility where bulk drug substances of mRNA and pDNA vaccines can be produced.

Key Points: 
  • Pyeongtaek Bio Plant possesses a GMP facility where bulk drug substances of mRNA and pDNA vaccines can be produced.
  • Hanmi Pharmaceutical Co., Ltd. is developing a full package to handle the prevention, diagnosis, and treatment of COVID-19.
  • Hanmi recently released 'Hanmi Cold-Mask nasal spray', whose main ingredient is -carrageenan (lambda-carrageenan) extract that can prevent respiratory viral infection.
  • Hanmi Bio Plant has two production buildings (Production Buildings 1 and 2) at the site with an area of 51,498 m2.

Global Carrageenan (Kappa, Iota, Lambda) Market Report 2020: Focus on Function Thickeners, Gelling Agent, & Stabilizers - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 5, 2021
Chemicals, Plastics, Manufacturing, Food and drink, Carrageenan, Microbicides, Polysaccharides, Foods, Edible algae, Chondrus crispus, Chemical substances

The global carrageenan market size is expected to reach USD 1.17 billion by 2027.

Key Points: 
  • The global carrageenan market size is expected to reach USD 1.17 billion by 2027.
  • Rising product penetration in pharmaceuticals, oil drilling, nutraceuticals, textile printing, cosmetics, and paper treatment industry is expected to boost the market growth.
  • Europe and North America emerged as the major markets for Carrageenan, together accounting for over 50.0% share of the global revenue in 2019.
  • Based on function, the stabilizing functionality of carrageenan is expected to witness strong gains over the next seven years.

Carrageenan Market Size Worth $1.17 Billion By 2027 | CAGR: 5.9%: Grand View Research, Inc.

Retrieved on: 
Monday, December 14, 2020
Food and drink, Foods, Polysaccharides, Microbicides, Carrageenan, Dairy products, Cheese, Chondrus crispus

SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- The global carrageenan market size is expected to reach USD 1.17 billion by 2027, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- The global carrageenan market size is expected to reach USD 1.17 billion by 2027, according to a new report by Grand View Research, Inc.
  • Carrageenan creates a fatty mouthfeel in food products, thus finds application in the production of vegetable-based dairy alternatives, low-fat cottage cheese, and low-fat cream, among others.
  • The functionality of carrageenan in meat products is associated with its thermally changeable gelation properties
    In Asia Pacific, China dominated the market in 2019.
  • Grand View Research has segmented the global carrageenan market on the basis of product, function, application, and region:

Carrageenan Market Size Worth $1.17 Billion By 2027 | CAGR: 5.9%: Grand View Research, Inc.

Retrieved on: 
Monday, December 14, 2020
Food and drink, Foods, Polysaccharides, Microbicides, Carrageenan, Dairy products, Cheese, Chondrus crispus

SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- The global carrageenan market size is expected to reach USD 1.17 billion by 2027, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- The global carrageenan market size is expected to reach USD 1.17 billion by 2027, according to a new report by Grand View Research, Inc.
  • Carrageenan creates a fatty mouthfeel in food products, thus finds application in the production of vegetable-based dairy alternatives, low-fat cottage cheese, and low-fat cream, among others.
  • The functionality of carrageenan in meat products is associated with its thermally changeable gelation properties
    In Asia Pacific, China dominated the market in 2019.
  • Grand View Research has segmented the global carrageenan market on the basis of product, function, application, and region:

Anti-COVID nasal spray formulated at University of Birmingham, UK is 'ready for use in humans'

Retrieved on: 
Thursday, November 19, 2020
Polysaccharides, Medicine, Clinical medicine, Chemical substances, Microbicides, Dosage forms, Carrageenan, Gellan gum, Antiviral drug, Adhesive, Nasal spray

This means that the normal procedures to take a new product to market are simplified, and the nasal spray could be commercially available very quickly.

Key Points: 
  • This means that the normal procedures to take a new product to market are simplified, and the nasal spray could be commercially available very quickly.
  • The formulation consists of an antiviral agent, carrageenan, and a gellan polysaccharide, both of which are already manufactured to pharmaceutical grade.
  • A pre-print study (not yet peer-reviewed) describes cell culture that tested the ability of the formulation to inhibit COVID-19 infection.
  • The research team screened FDA-approved polymers for their muco-adhesive properties and their ability to 'plume' when sprayed using a typical nasal spray applicator.

Orion Biotechnology Successfully Completes Phase 1 Clinical Trial of a First-in-Class Precision Engineered Ligand Analog for HIV Prevention

Retrieved on: 
Thursday, October 15, 2020
Microbicides, Clinical research, Design of experiments, Prevention of HIV/AIDS, Sexually transmitted diseases and infections

The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel.

Key Points: 
  • The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel.
  • During the multi-dose phase of the study, participants received study product once daily for five days.
  • The study enrolled a total of 30 healthy volunteers in Warsaw, Poland at the BioVirtus Phase 1 Research Site.
  • Dr. Ian McGowan, Chief Medical Officer at Orion Biotechnology added, Orion would like to thank the study participants, investigators, and researchers for their participation in this study.

Global $1+ Billion Carrageenan Gum Markets, 2019 & 2020-2026: Focus on Composition (Lambda, Iota, Kappa) & Applications (Meat & Poultry Dairy, Water Gels, Toothpaste, Others) - ResearchAndMarkets.com

Retrieved on: 
Friday, October 2, 2020
Retail, Chemicals, Plastics, Manufacturing, Food, Beverage, Food additives, Chemical substances, Food and drink, Polysaccharides, Carrageenan, Microbicides, Xanthan gum, Thickening agent, Gelatin dessert, Chewing gum, Gum, Guar gum

The sharp rise in demand for gelling agents, food additives fuels the growth of carrageenan gum market.

Key Points: 
  • The sharp rise in demand for gelling agents, food additives fuels the growth of carrageenan gum market.
  • However, the presence of substitutes in the market such as cellulose and xanthan is the only restraint for the carrageenan gum market.
  • The report provides a comprehensive view on analysis of Porter's Five Forces model for the carrageenan gum market.
  • Meat & poultry, dairy, water gels, toothpaste and others are some of the major applications for the carrageenan gum market.